Bupropiona (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bupropiona" in Portuguese language version.

refsWebsite

Global rank Portuguese rank

12doi.org

2^nd place

4^th place

11worldcat.org

5^th place

10nih.gov

4^th place

8^th place

2wiley.com

222^nd place

196^th place

1drugs.com

399^th place

289^th place

1thelancet.com

2,393^rd place

2,160^th place

1gpo.gov

1,360^th place

2,721^st place

1europa.eu

68^th place

56^th place

1cochrane.org

7,609^th place

6,177^th place

1drugbank.ca

4,294^th place

2,505^th place

1aomd.in

low place

1infarmed.pt

low place

1,711^th place

1emedexpert.com

low place

4,298^th place

aomd.in

Pitton Rissardo, Jamir; Fornari Caprara, AnaLetícia (2020). «Bupropion-associated movement disorders: A systematic review». Annals of Movement Disorders (em inglês) (2). 86 páginas. ISSN 2590-3446. doi:10.4103/AOMD.AOMD_35_19. Consultado em 13 de novembro de 2021

cochrane.org

«Bupropion for attention deficit hyperactivity disorder (ADHD) in adults». www.cochrane.org (em inglês). Consultado em 4 de agosto de 2019

doi.org

dx.doi.org

Geddes, John R.; Ioannidis, John P.A.; Tajika, Aran; Shinohara, Kiyomi; Imai, Hissei; Hayasaka, Yu; Takeshima, Nozomi; Egger, Matthias; Higgins, Julian P. T. (7 de abril de 2018). «Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis». The Lancet (em inglês). 391 (10128): 1357–1366. ISSN 0140-6736. PMID 29477251. doi:10.1016/S0140-6736(17)32802-7
Gartlehner, Gerald; Nussbaumer-Streit, Barbara; Gaynes, Bradley N; Forneris, Catherine A; Morgan, Laura C; Greenblatt, Amy; Wipplinger, Jörg; Lux, Linda J; Van Noord, Megan G (18 de Março de 2019). Cochrane Common Mental Disorders Group, ed. «Second-generation antidepressants for preventing seasonal affective disorder in adults». Cochrane Database of Systematic Reviews (em inglês). doi:10.1002/14651858.CD011268.pub3
Patel, Krisna; Allen, Sophie; Haque, Mariam N.; Angelescu, Ilinca; Baumeister, David; Tracy, Derek K. (Abril de 2016). «Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant». Therapeutic Advances in Psychopharmacology. 6 (2): 99–144. ISSN 2045-1253. PMC 4837968. PMID 27141292. doi:10.1177/2045125316629071
Safarinejad, Mohammad Reza (2010). «The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized study: BUPROPION IN SSRI-INDUCED MALE SEXUAL DYSFUNCTION». BJU International (em inglês). 106 (6): 840–847. doi:10.1111/j.1464-410X.2009.09154.x
Dwoskin, Linda P.; Rauhut, Anthony S.; King-Pospisil, Kelley A.; Bardo, Michael T. (2006). «Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent». CNS drug reviews. 12 (3-4): 178–207. ISSN 1080-563X. PMID 17227286. doi:10.1111/j.1527-3458.2006.00178.x
Meyer, Jeffrey H.; Goulding, Verdell S.; Wilson, Alan A.; Hussey, Doug; Christensen, Bruce K.; Houle, Sylvain (Agosto de 2002). «Bupropion occupancy of the dopamine transporter is low during clinical treatment». Psychopharmacology. 163 (1): 102–105. ISSN 0033-3158. PMID 12185406. doi:10.1007/s00213-002-1166-3
Stahl, Stephen M.; Pradko, James F.; Haight, Barbara R.; Modell, Jack G.; Rockett, Carol B.; Learned-Coughlin, Susan (2004). «A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor». Primary Care Companion to the Journal of Clinical Psychiatry. 6 (4): 159–166. ISSN 1523-5998. PMID 15361919. doi:10.4088/pcc.v06n0403
Simonsen, Ulf; Comerma-Steffensen, Simon; Andersson, Karl-Erik (Outubro de 2016). «Modulation of Dopaminergic Pathways to Treat Erectile Dysfunction». Basic & Clinical Pharmacology & Toxicology. 119 Suppl 3: 63–74. ISSN 1742-7843. PMID 27541930. doi:10.1111/bcpt.12653
Pandhare, Akash; Pappu, Aneesh Satya; Wilms, Henrik; Blanton, Michael Paul; Jansen, Michaela (Fevereiro de 2017). «The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors». Neuropharmacology. 113 (Pt A): 89–99. ISSN 1873-7064. PMC 5148637. PMID 27671323. doi:10.1016/j.neuropharm.2016.09.021
Kim, Eric J.; Felsovalyi, Klara; Young, Lauren M.; Shmelkov, Sergey V.; Grunebaum, Michael F.; Cardozo, Timothy (Setembro de 2018). «Molecular basis of atypicality of bupropion inferred from its receptor engagement in nervous system tissues». Psychopharmacology. 235 (9): 2643–2650. ISSN 1432-2072. PMID 29961917. doi:10.1007/s00213-018-4958-9
Arias, Hugo R. (Novembro de 2009). «Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions?». The International Journal of Biochemistry & Cell Biology. 41 (11): 2098–2108. ISSN 1878-5875. PMID 19497387. doi:10.1016/j.biocel.2009.05.015
Pitton Rissardo, Jamir; Fornari Caprara, AnaLetícia (2020). «Bupropion-associated movement disorders: A systematic review». Annals of Movement Disorders (em inglês) (2). 86 páginas. ISSN 2590-3446. doi:10.4103/AOMD.AOMD_35_19. Consultado em 13 de novembro de 2021

drugbank.ca

«Bupropion». www.drugbank.ca. Consultado em 4 de agosto de 2019

drugs.com

«Bupropion Hydrochloride Monograph for Professionals». Drugs.com (em inglês). Consultado em 4 de agosto de 2019

emedexpert.com

«Bupropion (Wellbutrin) - eMedExpert.com». www.emedexpert.com. Consultado em 4 de agosto de 2019

europa.eu

ema.europa.eu

«Mysimba» (PDF)

gpo.gov

permanent.access.gpo.gov

«Updates--September-October 2006 FDA Consumer». permanent.access.gpo.gov. Consultado em 4 de agosto de 2019

infarmed.pt

app7.infarmed.pt

«Wellbutrin XL»

nih.gov

ncbi.nlm.nih.gov

Geddes, John R.; Ioannidis, John P.A.; Tajika, Aran; Shinohara, Kiyomi; Imai, Hissei; Hayasaka, Yu; Takeshima, Nozomi; Egger, Matthias; Higgins, Julian P. T. (7 de abril de 2018). «Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis». The Lancet (em inglês). 391 (10128): 1357–1366. ISSN 0140-6736. PMID 29477251. doi:10.1016/S0140-6736(17)32802-7
Patel, Krisna; Allen, Sophie; Haque, Mariam N.; Angelescu, Ilinca; Baumeister, David; Tracy, Derek K. (Abril de 2016). «Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant». Therapeutic Advances in Psychopharmacology. 6 (2): 99–144. ISSN 2045-1253. PMC 4837968. PMID 27141292. doi:10.1177/2045125316629071
Wilkes, Scott (2008). «The use of bupropion SR in cigarette smoking cessation». International Journal of Chronic Obstructive Pulmonary Disease. 3 (1): 45–53. ISSN 1176-9106. PMC 2528204. PMID 18488428
Dwoskin, Linda P.; Rauhut, Anthony S.; King-Pospisil, Kelley A.; Bardo, Michael T. (2006). «Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent». CNS drug reviews. 12 (3-4): 178–207. ISSN 1080-563X. PMID 17227286. doi:10.1111/j.1527-3458.2006.00178.x
Meyer, Jeffrey H.; Goulding, Verdell S.; Wilson, Alan A.; Hussey, Doug; Christensen, Bruce K.; Houle, Sylvain (Agosto de 2002). «Bupropion occupancy of the dopamine transporter is low during clinical treatment». Psychopharmacology. 163 (1): 102–105. ISSN 0033-3158. PMID 12185406. doi:10.1007/s00213-002-1166-3
Stahl, Stephen M.; Pradko, James F.; Haight, Barbara R.; Modell, Jack G.; Rockett, Carol B.; Learned-Coughlin, Susan (2004). «A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor». Primary Care Companion to the Journal of Clinical Psychiatry. 6 (4): 159–166. ISSN 1523-5998. PMID 15361919. doi:10.4088/pcc.v06n0403
Simonsen, Ulf; Comerma-Steffensen, Simon; Andersson, Karl-Erik (Outubro de 2016). «Modulation of Dopaminergic Pathways to Treat Erectile Dysfunction». Basic & Clinical Pharmacology & Toxicology. 119 Suppl 3: 63–74. ISSN 1742-7843. PMID 27541930. doi:10.1111/bcpt.12653
Pandhare, Akash; Pappu, Aneesh Satya; Wilms, Henrik; Blanton, Michael Paul; Jansen, Michaela (Fevereiro de 2017). «The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors». Neuropharmacology. 113 (Pt A): 89–99. ISSN 1873-7064. PMC 5148637. PMID 27671323. doi:10.1016/j.neuropharm.2016.09.021
Kim, Eric J.; Felsovalyi, Klara; Young, Lauren M.; Shmelkov, Sergey V.; Grunebaum, Michael F.; Cardozo, Timothy (Setembro de 2018). «Molecular basis of atypicality of bupropion inferred from its receptor engagement in nervous system tissues». Psychopharmacology. 235 (9): 2643–2650. ISSN 1432-2072. PMID 29961917. doi:10.1007/s00213-018-4958-9
Arias, Hugo R. (Novembro de 2009). «Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions?». The International Journal of Biochemistry & Cell Biology. 41 (11): 2098–2108. ISSN 1878-5875. PMID 19497387. doi:10.1016/j.biocel.2009.05.015

thelancet.com

Geddes, John R.; Ioannidis, John P.A.; Tajika, Aran; Shinohara, Kiyomi; Imai, Hissei; Hayasaka, Yu; Takeshima, Nozomi; Egger, Matthias; Higgins, Julian P. T. (7 de abril de 2018). «Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis». The Lancet (em inglês). 391 (10128): 1357–1366. ISSN 0140-6736. PMID 29477251. doi:10.1016/S0140-6736(17)32802-7

wiley.com

doi.wiley.com

Gartlehner, Gerald; Nussbaumer-Streit, Barbara; Gaynes, Bradley N; Forneris, Catherine A; Morgan, Laura C; Greenblatt, Amy; Wipplinger, Jörg; Lux, Linda J; Van Noord, Megan G (18 de Março de 2019). Cochrane Common Mental Disorders Group, ed. «Second-generation antidepressants for preventing seasonal affective disorder in adults». Cochrane Database of Systematic Reviews (em inglês). doi:10.1002/14651858.CD011268.pub3
Safarinejad, Mohammad Reza (2010). «The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized study: BUPROPION IN SSRI-INDUCED MALE SEXUAL DYSFUNCTION». BJU International (em inglês). 106 (6): 840–847. doi:10.1111/j.1464-410X.2009.09154.x

worldcat.org

Geddes, John R.; Ioannidis, John P.A.; Tajika, Aran; Shinohara, Kiyomi; Imai, Hissei; Hayasaka, Yu; Takeshima, Nozomi; Egger, Matthias; Higgins, Julian P. T. (7 de abril de 2018). «Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis». The Lancet (em inglês). 391 (10128): 1357–1366. ISSN 0140-6736. PMID 29477251. doi:10.1016/S0140-6736(17)32802-7
Patel, Krisna; Allen, Sophie; Haque, Mariam N.; Angelescu, Ilinca; Baumeister, David; Tracy, Derek K. (Abril de 2016). «Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant». Therapeutic Advances in Psychopharmacology. 6 (2): 99–144. ISSN 2045-1253. PMC 4837968. PMID 27141292. doi:10.1177/2045125316629071
Wilkes, Scott (2008). «The use of bupropion SR in cigarette smoking cessation». International Journal of Chronic Obstructive Pulmonary Disease. 3 (1): 45–53. ISSN 1176-9106. PMC 2528204. PMID 18488428
Dwoskin, Linda P.; Rauhut, Anthony S.; King-Pospisil, Kelley A.; Bardo, Michael T. (2006). «Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent». CNS drug reviews. 12 (3-4): 178–207. ISSN 1080-563X. PMID 17227286. doi:10.1111/j.1527-3458.2006.00178.x
Meyer, Jeffrey H.; Goulding, Verdell S.; Wilson, Alan A.; Hussey, Doug; Christensen, Bruce K.; Houle, Sylvain (Agosto de 2002). «Bupropion occupancy of the dopamine transporter is low during clinical treatment». Psychopharmacology. 163 (1): 102–105. ISSN 0033-3158. PMID 12185406. doi:10.1007/s00213-002-1166-3
Stahl, Stephen M.; Pradko, James F.; Haight, Barbara R.; Modell, Jack G.; Rockett, Carol B.; Learned-Coughlin, Susan (2004). «A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor». Primary Care Companion to the Journal of Clinical Psychiatry. 6 (4): 159–166. ISSN 1523-5998. PMID 15361919. doi:10.4088/pcc.v06n0403
Simonsen, Ulf; Comerma-Steffensen, Simon; Andersson, Karl-Erik (Outubro de 2016). «Modulation of Dopaminergic Pathways to Treat Erectile Dysfunction». Basic & Clinical Pharmacology & Toxicology. 119 Suppl 3: 63–74. ISSN 1742-7843. PMID 27541930. doi:10.1111/bcpt.12653
Pandhare, Akash; Pappu, Aneesh Satya; Wilms, Henrik; Blanton, Michael Paul; Jansen, Michaela (Fevereiro de 2017). «The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors». Neuropharmacology. 113 (Pt A): 89–99. ISSN 1873-7064. PMC 5148637. PMID 27671323. doi:10.1016/j.neuropharm.2016.09.021
Kim, Eric J.; Felsovalyi, Klara; Young, Lauren M.; Shmelkov, Sergey V.; Grunebaum, Michael F.; Cardozo, Timothy (Setembro de 2018). «Molecular basis of atypicality of bupropion inferred from its receptor engagement in nervous system tissues». Psychopharmacology. 235 (9): 2643–2650. ISSN 1432-2072. PMID 29961917. doi:10.1007/s00213-018-4958-9
Arias, Hugo R. (Novembro de 2009). «Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions?». The International Journal of Biochemistry & Cell Biology. 41 (11): 2098–2108. ISSN 1878-5875. PMID 19497387. doi:10.1016/j.biocel.2009.05.015
Pitton Rissardo, Jamir; Fornari Caprara, AnaLetícia (2020). «Bupropion-associated movement disorders: A systematic review». Annals of Movement Disorders (em inglês) (2). 86 páginas. ISSN 2590-3446. doi:10.4103/AOMD.AOMD_35_19. Consultado em 13 de novembro de 2021